Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.

Gullick NJ, Ibrahim F, Scott IC, Vincent A, Cope AP, Garrood T, Panayi GS, Scott DL, Kirkham BW; TITRATE Programme Investigators.

BMC Rheumatol. 2019 Feb 25;3:6. doi: 10.1186/s41927-019-0054-y. eCollection 2019.

2.

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.

Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Christidis D, Galloway S, Hayes E, Jeffries A, Mercer S, Mooney J, van Leuven S, Galloway J.

Rheumatology (Oxford). 2017 Dec 1;56(12):2257. doi: 10.1093/rheumatology/kex389. No abstract available.

PMID:
29029272
3.

Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial.

Tjärnlund A, Tang Q, Wick C, Dastmalchi M, Mann H, Tomasová Studýnková J, Chura R, Gullick NJ, Salerno R, Rönnelid J, Alexanderson H, Lindroos E, Aggarwal R, Gordon P, Vencovsky J, Lundberg IE.

Ann Rheum Dis. 2018 Jan;77(1):55-62. doi: 10.1136/annrheumdis-2017-211751. Epub 2017 Oct 9.

PMID:
28993346
4.

Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data.

Gullick NJ, Mian AN, Ibrahim F, Walker D, Hassell A, Kiely PDW, Walsh DA, Young A, Scott DL; TITRATE Programme Investigators.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):810-815. Epub 2017 May 8.

PMID:
28516868
5.

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.

Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Christidis D, Galloway S, Hayes E, Jeffries A, Mercer S, Mooney J, van Leuven S, Galloway J; BSR and BHPR Standards, Guidelines and Audit Working Group.

Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479. No abstract available. Erratum in: Rheumatology (Oxford). 2017 Dec 1;56(12 ):2257.

PMID:
28339817
6.

Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound.

Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, Garrood T.

BMC Musculoskelet Disord. 2016 Sep 23;17(1):404.

7.

Patient involvement in rheumatology outpatient service design and delivery: a case study.

de Souza S, Galloway J, Simpson C, Chura R, Dobson J, Gullick NJ, Steer S, Lempp H.

Health Expect. 2017 Jun;20(3):508-518. doi: 10.1111/hex.12478. Epub 2016 Jun 27.

8.

TNF-α blockade induces IL-10 expression in human CD4+ T cells.

Evans HG, Roostalu U, Walter GJ, Gullick NJ, Frederiksen KS, Roberts CA, Sumner J, Baeten DL, Gerwien JG, Cope AP, Geissmann F, Kirkham BW, Taams LS.

Nat Commun. 2014;5:3199. doi: 10.1038/ncomms4199.

9.

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.

Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW.

Arthritis Rheumatol. 2014 May;66(5):1272-81. doi: 10.1002/art.38376.

10.

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review.

Al-Shakarchi I, Gullick NJ, Scott DL.

Patient Prefer Adherence. 2013 Jul 4;7:653-66. doi: 10.2147/PPA.S41433. Print 2013.

11.

Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.

Gullick NJ, Abozaid HS, Jayaraj DM, Evans HG, Scott DL, Choy EH, Taams LS.

Clin Exp Immunol. 2013 Nov;174(2):292-301. doi: 10.1111/cei.12167.

12.

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Walter GJ, Evans HG, Menon B, Gullick NJ, Kirkham BW, Cope AP, Geissmann F, Taams LS.

Arthritis Rheum. 2013 Mar;65(3):627-38. doi: 10.1002/art.37832.

13.

Drug therapy of inflammatory arthritis.

Gullick NJ, Scott DL.

Clin Med (Lond). 2012 Aug;12(4):357-63.

14.

Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years.

Gullick NJ, Oakley SP, Zain A, Gibson T, Jones T, Mistlin A, Rees JD, Panayi GS, Kirkham BW.

Rheumatology (Oxford). 2012 Apr;51(4):759-61. doi: 10.1093/rheumatology/ker399. Epub 2012 Jan 5. No abstract available.

15.

FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+CD25- responder T cells, but not CD4+CD25+ regulatory T cells.

Jagger AL, Evans HG, Walter GJ, Gullick NJ, Menon B, Ballantine LE, Gracie A, Magerus-Chatinet A, Tiemessen MM, Geissmann F, Rieux-Laucat F, Taams LS.

J Autoimmun. 2012 Feb;38(1):29-38. doi: 10.1016/j.jaut.2011.11.015. Epub 2011 Dec 24.

PMID:
22197557
16.

Co-morbidities in established rheumatoid arthritis.

Gullick NJ, Scott DL.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):469-83. doi: 10.1016/j.berh.2011.10.009. Review.

PMID:
22137918
17.

Rheumatoid arthritis: clinical utility of the RAID (RA impact of disease) score.

Gullick NJ, Scott DL.

Nat Rev Rheumatol. 2011 Jul 19;7(9):499-500. doi: 10.1038/nrrheum.2011.105. No abstract available.

PMID:
21769131
18.

Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint.

Gullick NJ, Evans HG, Church LD, Jayaraj DM, Filer A, Kirkham BW, Taams LS.

PLoS One. 2010 Sep 1;5(9). pii: e12516. doi: 10.1371/journal.pone.0012516.

19.

In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses.

Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, Kirkham BW, Taams LS.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6232-7. doi: 10.1073/pnas.0808144106. Epub 2009 Mar 26.

20.

An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis.

Macedo A, Oakley S, Gullick N, Kirkham B.

J Rheumatol. 2009 Feb;36(2):225-30. doi: 10.3899/jrheum.071001. Epub 2009 Jan 22.

PMID:
19208557
21.

A synovial pathergy reaction leading to a pseudo-septic arthritis and a diagnosis of Behçet's disease.

Humby F, Gullick N, Kelly S, Pitzalis C, Oakley SP.

Rheumatology (Oxford). 2008 Aug;47(8):1255-6. doi: 10.1093/rheumatology/ken194. Epub 2008 Jun 4. No abstract available.

PMID:
18524807

Supplemental Content

Loading ...
Support Center